938 results The honeymoon phase of the Foreign Subsidies Regulation is over! Paperwork, paperwork, paperwork. The industry voices have been clear about the Foreign Subsidies Regulation. But what is the authority’s view? We provide an update on recent developments, including the European Commission’s first policy brief. ECJ accepts carve-out Italy in Commission’s Amazon Buy Box investigation The EU Court of Justice dismissed Amazon’s claim that the exclusion of Italy from the European Commission’s investigation into its Buy Box feature deprived Amazon of its protection against a parallel investigation by the Italian competition authority. European Court of Justice plays hardball in Sports rulings The rulings by the European Court of Justice (ECJ) on the discretionary powers of international sports associations to authorise alternative competitions show that the specifics of sports are no reason to tread lightly when applying EU competition rules. The vertical fight continues: two more cases on vertical restraints Companies should not take competition rules lightly in their supply relationships. The EU General Court's Valve judgment and the ACM's LG decision illustrate the consistent attention to vertical restraints. Stibbe Brussels reinforces Public Law and EU/Competition Law practices with two Counsel appointments Stibbe Brussels has promoted Sophie Adriaenssen to Counsel in its Public Law practice group and has welcomed Quentin Declève as Counsel in its EU/Competition Law practice. The appointments are effective as per 1 January 2023. Stibbe Brussel versterkt praktijken Publiekrecht en EU/Competition met twee counselbenoemingen Stibbe Brussel heeft Sophie Adriaenssen benoemd tot Counsel in zijn praktijkgroep Publiekrecht. Het kantoor heeft daarnaast Quentin Declève verwelkomd als Counsel in zijn praktijkgroep EU/Competition. De nieuwe benoemingen gelden vanaf 1 januari 2023. Stibbe Bruxelles renforce ses pratiques en droit public et en droit de l'UE/de la concurrence par la nomination de deux Counsel Le bureau bruxellois de Stibbe a nommé Sophie Adriaenssen en tant que Counsel au sein de sa pratique de droit public. Le cabinet a également accueilli Quentin Declève en tant que Counsel au sein de sa pratique de droit de l'UE/de la concurrence. Belgian watchdog tackles bid rigging In recent cases in the fire protection and private security sectors, the Belgian Competition Authority has made the prosecution of bid-rigging one of its top priorities, imposing hefty fines on infringers for their participation in cartel schemes. If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug. The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite. Qualcomm falls prey to EU court’s predatory pricing ruling The EU General Court confirms that Qualcomm’s below-cost pricing strategy designed to eliminate competition was predatory. This judgment, the first of its kind in over a decade, provides useful guidance on predatory pricing practices. Verticale prijsbinding: handhaving, boetes en schadeclaims We bespreken de wijze waarop bedrijven hun afnemers ongeoorloofd dwingen tot het rekenen van minimumprijzen en waarom dat niet mag. De ACM handhaaft streng en leveranciers kunnen rekenen op hoge boetes en schadeclaims van gedupeerde consumenten. ECJ in Towercast: plan C for tackling concentrations? Companies beware: completed non-notifiable concentrations do not necessarily go scot-free. An ex post abuse-of-dominance investigation by national competition authorities (NCA) could still loom. The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines. Sharing is caring? Commission can take over NCA probe The EU case cooperation mechanism does not create any rights for companies to have their case dealt with by a particular competition authority. Companies should therefore factor the dynamics of this cooperation mechanism into their defence strategies. Mayday, Mayday: Pay day! The Commission’s fight to avoid paying interest to Deutsche Telekom is over. The ECJ upheld the right of companies to receive interest on unduly collected antitrust fines, carrying a hefty price tag for the Commission. Get ready for more action! Dutch investment screening continues to evolve Dutch investment screening is rapidly expanding: since June, the proposal for a separate defence regime has been published and the intended expansion of the regime of the Vifo Act to include AI and biotech has been announced. Reason for a quick update! Widening the net: The Dutch government proposes to broaden the scope of the Vifo Act The Vifo Act continues to evolve: Dutch government to extend the scope of the general Dutch FDI screening regime to cover six additional technologies. Pagination Previous page Page 45 Current page 46 Page 47 Page 48 Next page
The honeymoon phase of the Foreign Subsidies Regulation is over! Paperwork, paperwork, paperwork. The industry voices have been clear about the Foreign Subsidies Regulation. But what is the authority’s view? We provide an update on recent developments, including the European Commission’s first policy brief.
ECJ accepts carve-out Italy in Commission’s Amazon Buy Box investigation The EU Court of Justice dismissed Amazon’s claim that the exclusion of Italy from the European Commission’s investigation into its Buy Box feature deprived Amazon of its protection against a parallel investigation by the Italian competition authority.
European Court of Justice plays hardball in Sports rulings The rulings by the European Court of Justice (ECJ) on the discretionary powers of international sports associations to authorise alternative competitions show that the specifics of sports are no reason to tread lightly when applying EU competition rules.
The vertical fight continues: two more cases on vertical restraints Companies should not take competition rules lightly in their supply relationships. The EU General Court's Valve judgment and the ACM's LG decision illustrate the consistent attention to vertical restraints.
Stibbe Brussels reinforces Public Law and EU/Competition Law practices with two Counsel appointments Stibbe Brussels has promoted Sophie Adriaenssen to Counsel in its Public Law practice group and has welcomed Quentin Declève as Counsel in its EU/Competition Law practice. The appointments are effective as per 1 January 2023.
Stibbe Brussel versterkt praktijken Publiekrecht en EU/Competition met twee counselbenoemingen Stibbe Brussel heeft Sophie Adriaenssen benoemd tot Counsel in zijn praktijkgroep Publiekrecht. Het kantoor heeft daarnaast Quentin Declève verwelkomd als Counsel in zijn praktijkgroep EU/Competition. De nieuwe benoemingen gelden vanaf 1 januari 2023.
Stibbe Bruxelles renforce ses pratiques en droit public et en droit de l'UE/de la concurrence par la nomination de deux Counsel Le bureau bruxellois de Stibbe a nommé Sophie Adriaenssen en tant que Counsel au sein de sa pratique de droit public. Le cabinet a également accueilli Quentin Declève en tant que Counsel au sein de sa pratique de droit de l'UE/de la concurrence.
Belgian watchdog tackles bid rigging In recent cases in the fire protection and private security sectors, the Belgian Competition Authority has made the prosecution of bid-rigging one of its top priorities, imposing hefty fines on infringers for their participation in cartel schemes.
If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.
The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite.
Qualcomm falls prey to EU court’s predatory pricing ruling The EU General Court confirms that Qualcomm’s below-cost pricing strategy designed to eliminate competition was predatory. This judgment, the first of its kind in over a decade, provides useful guidance on predatory pricing practices.
Verticale prijsbinding: handhaving, boetes en schadeclaims We bespreken de wijze waarop bedrijven hun afnemers ongeoorloofd dwingen tot het rekenen van minimumprijzen en waarom dat niet mag. De ACM handhaaft streng en leveranciers kunnen rekenen op hoge boetes en schadeclaims van gedupeerde consumenten.
ECJ in Towercast: plan C for tackling concentrations? Companies beware: completed non-notifiable concentrations do not necessarily go scot-free. An ex post abuse-of-dominance investigation by national competition authorities (NCA) could still loom.
The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines.
Sharing is caring? Commission can take over NCA probe The EU case cooperation mechanism does not create any rights for companies to have their case dealt with by a particular competition authority. Companies should therefore factor the dynamics of this cooperation mechanism into their defence strategies.
Mayday, Mayday: Pay day! The Commission’s fight to avoid paying interest to Deutsche Telekom is over. The ECJ upheld the right of companies to receive interest on unduly collected antitrust fines, carrying a hefty price tag for the Commission.
Get ready for more action! Dutch investment screening continues to evolve Dutch investment screening is rapidly expanding: since June, the proposal for a separate defence regime has been published and the intended expansion of the regime of the Vifo Act to include AI and biotech has been announced. Reason for a quick update!
Widening the net: The Dutch government proposes to broaden the scope of the Vifo Act The Vifo Act continues to evolve: Dutch government to extend the scope of the general Dutch FDI screening regime to cover six additional technologies.